| Study Visit |
Variable |
Statistic |
Group A
(Treatment naïve) |
Group B
(Treatment experienced) |
Total |
p-value |
| (N=155) |
(N=102) |
(N=257) |
| Persistence |
|
|
|
|
|
| All Subjects Enrolled |
N |
155 |
102 |
257 |
|
| |
Never started treatment 1 |
N |
9 (5.8%) |
14 (13.7%) |
23 (9.0%) |
- |
| 30-Day |
Persistent |
Yes
No |
132 (85.2%)
14 (9.0%) |
82 (80.4%)
6 (5.9%) |
214 (83.3%)
20 (7.8%) |
.0720
Chi-Square test |
| 90-Day |
Persistent |
Yes
No |
126 (81.3%)
20 (12.9%) |
76 (74.5%)
12 (11.8%) |
202 (78.6%)
32 (12.5%) |
.0937
Chi-Square test |
| All Subjects Starting Treatment 1 |
N |
146 |
88 |
234 |
- |
| 30-Day |
Persistent |
Yes
No |
132 (90.4%)
14 (9.6%) |
82 (93.2%)
6 (6.8%) |
214 (91.5%)
20 (8.6%) |
.4627
Chi-Square test |
| 90-Day |
Persistent |
Yes
No |
126 (86.3%)
20 (13.7%) |
76 (86.4%)
12 (13.6%) |
202 (86.3%)
32 (13.7%) |
.9893
Chi-Square test |
| Compliance |
|
|
|
|
|
| 30-Day |
Percentage of days compliant |
N
M ± SD
Range
Mdn |
134
95.3 ± 14.7
5, 100
100.0 |
79
96.5 ± 11.7
8, 100
100.0 |
213
95.7 ± 13.7
5, 100
100.0 |
.5307
Unpaired t-test |
| 90-Day |
Percentage of days compliant |
N
M ± SD
Range
Mdn |
121
97.2 ± 8.6
45, 100
100.0 |
75
97.6 ± 4.2
80, 100
100.0 |
196
97.4 ± 7.3
45, 100
100.0 |
.6707
Unpaired t-test |
